Jointown Pharmaceutical Group Co., Ltd (SHA:600998)
China
· Delayed Price · Currency is CNY 5.33
+0.05 (0.95%)
Mar 10, 2026, 3:00 PM CST
SHA:600998 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 26,328 | 25,148 | 26,691 | 24,052 | 26,919 | 33,241 | Upgrade
|
| Market Cap Growth | 6.57% | -5.78% | 10.97% | -10.65% | -19.02% | 27.82% | Upgrade
|
| Enterprise Value | 32,732 | 31,376 | 33,203 | 31,612 | 39,715 | 45,758 | Upgrade
|
| Last Close Price | 5.28 | 4.93 | 5.05 | 4.35 | 4.79 | 5.73 | Upgrade
|
| PE Ratio | 9.61 | 10.03 | 12.28 | 11.54 | 11.00 | 10.81 | Upgrade
|
| Forward PE | 11.30 | 12.69 | 10.60 | 9.52 | 10.44 | 15.14 | Upgrade
|
| PS Ratio | 0.17 | 0.17 | 0.18 | 0.17 | 0.22 | 0.30 | Upgrade
|
| PB Ratio | 0.75 | 0.75 | 0.91 | 0.84 | 0.99 | 1.30 | Upgrade
|
| P/TBV Ratio | 1.13 | 1.12 | 1.25 | 1.20 | 1.44 | 1.95 | Upgrade
|
| P/FCF Ratio | 12.82 | 11.94 | 7.22 | 8.77 | 12.99 | 16.73 | Upgrade
|
| P/OCF Ratio | 7.69 | 8.16 | 5.62 | 6.03 | 7.78 | 9.65 | Upgrade
|
| EV/Sales Ratio | 0.21 | 0.21 | 0.22 | 0.23 | 0.32 | 0.41 | Upgrade
|
| EV/EBITDA Ratio | 7.56 | 6.80 | 7.02 | 7.16 | 10.93 | 10.80 | Upgrade
|
| EV/EBIT Ratio | 9.30 | 8.00 | 8.19 | 8.34 | 12.86 | 12.29 | Upgrade
|
| EV/FCF Ratio | 15.94 | 14.89 | 8.98 | 11.53 | 19.16 | 23.03 | Upgrade
|
| Debt / Equity Ratio | 0.46 | 0.39 | 0.50 | 0.53 | 0.65 | 0.68 | Upgrade
|
| Debt / EBITDA Ratio | 3.69 | 2.79 | 3.05 | 3.35 | 4.67 | 4.14 | Upgrade
|
| Debt / FCF Ratio | 7.78 | 6.27 | 3.99 | 5.53 | 8.43 | 8.82 | Upgrade
|
| Net Debt / Equity Ratio | -0.06 | -0.15 | -0.08 | -0.08 | -0.04 | 0.10 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.52 | -1.12 | -0.50 | -0.55 | -0.31 | 0.61 | Upgrade
|
| Net Debt / FCF Ratio | -1.06 | -2.45 | -0.64 | -0.88 | -0.54 | 1.31 | Upgrade
|
| Asset Turnover | 1.48 | 1.56 | 1.62 | 1.58 | 1.47 | 1.46 | Upgrade
|
| Inventory Turnover | 6.87 | 6.52 | 7.40 | 7.92 | 7.44 | 7.00 | Upgrade
|
| Quick Ratio | 0.85 | 0.82 | 0.83 | 0.85 | 0.90 | 0.92 | Upgrade
|
| Current Ratio | 1.25 | 1.27 | 1.26 | 1.27 | 1.29 | 1.29 | Upgrade
|
| Return on Equity (ROE) | 9.11% | 8.84% | 7.87% | 8.20% | 9.90% | 14.23% | Upgrade
|
| Return on Assets (ROA) | 2.06% | 2.51% | 2.74% | 2.66% | 2.31% | 3.06% | Upgrade
|
| Return on Invested Capital (ROIC) | 8.16% | 10.82% | 11.63% | 11.69% | 8.84% | 11.07% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.30% | 10.90% | 12.40% | 11.60% | 10.10% | 12.60% | Upgrade
|
| Earnings Yield | 10.58% | 9.97% | 8.14% | 8.67% | 9.10% | 9.25% | Upgrade
|
| FCF Yield | 7.80% | 8.38% | 13.86% | 11.40% | 7.70% | 5.98% | Upgrade
|
| Dividend Yield | 3.80% | 4.06% | 3.84% | 4.27% | 2.33% | 3.24% | Upgrade
|
| Payout Ratio | 54.05% | 61.96% | 75.20% | 66.58% | 68.69% | 23.99% | Upgrade
|
| Buyback Yield / Dilution | -1.48% | 0.81% | 4.14% | -1.68% | 2.84% | 3.46% | Upgrade
|
| Total Shareholder Return | 2.32% | 4.87% | 7.98% | 2.58% | 5.17% | 6.71% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.